DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Optimark (Gadoversetamide) - Serious Reactions - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Reactions (177)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Optimark (Gadoversetamide) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 177   Next >>

Possible Optimark side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: male, weighing 91.0 kg (200.2 pounds)

Reactions: Pain, Joint Contracture, Muscle Fibrosis, Muscle Tightness, Myosclerosis, Fatigue, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Depression, Injury, Extremity Contracture, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Anxiety, Emotional Distress, Activities of Daily Living Impaired, Frustration

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Indication: Osteomyelitis

Gadolinium IN Unspecified Drug
    Indication: Diabetic Foot

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-05
    End date: 2002-11-05

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-01-14
    End date: 2005-01-14

Magnevist
    Dosage: 15 ml, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Magnevist
    Dosage: unk unk, once
    Start date: 2005-01-25
    End date: 2005-01-25

Magnevist
    Dosage: unk unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-11-15
    End date: 2002-11-15

Magnevist
    Dosage: 19 ml, once
    Start date: 2004-07-16
    End date: 2004-07-16

Multihance
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Prohance
    Dosage: unk unk, once
    Indication: Angiogram
    Start date: 2002-10-16
    End date: 2002-10-16

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Clonidine; Fosrenol; Accupril; Renagel; Phoslo; Diatx; Vitamins NOS; Temazepam; Novolin R; Minoxidil; Insulin [insulin]; Coumadin; Procrit; Lasix



Possible Optimark side effects in 49 year old male

Reported by a lawyer from United States on 2012-08-02

Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)

Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Start date: 2004-05-19
    End date: 2004-05-19

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-05-19
    End date: 2006-05-19

Magnevist
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-10-13
    End date: 2006-10-13

Magnevist
    Dosage: 20 ml, unk
    Start date: 2006-10-17
    End date: 2006-10-17

Multihance
    Indication: Product Used FOR Unknown Indication

Omniscan

Omniscan
    Dosage: 50 ml omniscan+co2
    Indication: Fistulogram
    Start date: 2006-08-04
    End date: 2006-08-04

Omniscan
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-05
    End date: 2006-08-05

Optimark
    Indication: Product Used FOR Unknown Indication

Prohance
    Indication: Computerised Tomogram Head
    Start date: 2004-05-19
    End date: 2004-05-19

Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine



Possible Optimark side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: female

Reactions: Pruritus, Pain, Joint Contracture, Myosclerosis, Skin Ulcer, Injury, Fibrosis, General Physical Health Deterioration, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Tendon Disorder, Disability

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Omniscan
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: 56 year old female

Reactions: Pruritus, Abasia, Pain, Joint Contracture, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Rash, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Mobility Decreased, Scar

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-05-21
    End date: 2004-05-21

Magnevist
    Indication: Renal Mass

Optimark
    Indication: Muscular Weakness

Optimark
    Indication: Disorientation

Optimark
    Indication: Headache

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Other drugs received by patient: Lantus; Sensipar; Slow Release Iron; Prograf; Phoslo; Renvela; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone; Procrit; Atenolol



Possible Optimark side effects in male

Reported by a physician from United States on 2012-07-30

Patient: male, weighing 110.7 kg (243.5 pounds)

Reactions: Hyperbilirubinaemia, Chest Pain, Pleural Effusion, Depression, Contrast Media Allergy, Acute Myocardial Infarction, Cardiac Failure Congestive, Vomiting, Cellulitis, Nausea, Coronary Artery Disease, Hyponatraemia, Bacterial Disease Carrier, Ventricular Tachycardia, Hypoalbuminaemia, Gallbladder Polyp, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Optimark
    Dosage: 15 ml, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2007-01-17
    End date: 2007-01-17

Optimark

Other drugs received by patient: Aciphex; Ibuprofen; Multiple Vitamins; Crestor; Levitra; Lisinopril



Possible Optimark side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-27

Patient: female

Reactions: Pruritus, Pain, Muscle Contracture, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Skin Ulcer, Arthralgia, Fibrosis, Injury, Disability

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Magnevist
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging



Possible Optimark side effects in female

Reported by a lawyer from United States on 2012-07-26

Patient: female, weighing 118.8 kg (261.4 pounds)

Reactions: Lymphadenopathy, Septic Encephalopathy, Tachycardia, Decubitus Ulcer, Upper Respiratory Tract Infection, Iron Deficiency Anaemia, Dermatitis, Graft Thrombosis, Oedema Peripheral, Pulmonary Oedema, Hyperphosphataemia, Hypertensive Heart Disease, Hypotension, Nephrogenic Systemic Fibrosis, Gene Mutation Identification Test Positive, Electrocardiogram QT Prolonged, Wheezing, Drug Interaction, Fall, Blood Bilirubin Decreased, Hyperparathyroidism, Erosive Oesophagitis, Graft Infection, Fluid Overload, Dyspnoea, Haemorrhoids, Syncope, Pericarditis, Sepsis, Sinus Disorder, Hypothyroidism, Asthma, Bronchopneumonia, Pleuritic Pain, Coagulopathy, Pulmonary Embolism, Cardiac Failure Acute, Duodenitis, Colon Adenoma, Nodule, Electrocardiogram T Wave Abnormal, Carpal Tunnel Syndrome, Abscess Limb, Pain in Extremity, Breast Calcifications, Respiratory Distress, Insomnia, Dyslipidaemia, Diverticulum Intestinal Haemorrhagic, Pain, Gastritis, Hypokalaemia, Myalgia, Neuropathy Peripheral, Pericardial RUB, Azotaemia, Gastrooesophageal Reflux Disease, Jugular Vein Thrombosis, Systemic Sclerosis, Tracheobronchitis, Migraine, Haemoptysis, Atrial Fibrillation, Renal Failure Chronic, Pneumonia Bacterial, Diarrhoea, Gastroenteritis, Protein C Deficiency, Hypertension, Superior Vena Cava Syndrome, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gadolinium
    Dosage: unk, single
    Indication: Angiogram
    Start date: 2004-02-06
    End date: 2004-02-06

Optimark
    Dosage: 15 ml, single
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-08-31
    End date: 2005-08-31

Other drugs received by patient: Nephro-Vite / 01801401 /; Guaifenesin DM; Diovan; Renagel; Lorazepam; Accupril; Azithromycin; Tylenol with Codein #3; Propoxyphene HCL; Zosyn; Albuterol; Atenolol; Epogen; Calcitriol; Lasix; Atrovent; Hydralazine HCL



Possible Optimark side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24

Patient: 56 year old female

Reactions: Pruritus, Abasia, Joint Contracture, Pain, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Fibrosis, Injury, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, DRY Skin, Nephrogenic Systemic Fibrosis, Rash, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Scar, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-05-28
    End date: 1999-05-28

Magnevist
    Indication: Renal Mass

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-05-21
    End date: 2004-05-21

Optimark
    Dosage: 15 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2006-06-02
    End date: 2006-06-02

Optimark
    Indication: Muscular Weakness

Optimark
    Indication: Headache

Optimark
    Indication: Disorientation

Other drugs received by patient: Sensipar; Renvela; Prograf; Prednisone; Procrit; Phoslo; Lantus; Slow Release Iron; Atenolol; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]



Possible Optimark side effects in 79 year old female

Reported by a physician from United States on 2012-07-20

Patient: 79 year old female, weighing 63.6 kg (140.0 pounds)

Reactions: Skin Wrinkling, Pruritus, Pain, Muscle Rigidity, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Musculoskeletal Stiffness, Oedema, Injury, Extremity Contracture, Skin Hypertrophy, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Tightness, Emotional Distress, Anxiety, Arthralgia

Adverse event resulted in: death

Drug(s) suspected as cause:
Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Gadolinium Zeolite
    Start date: 2005-08-16
    End date: 2005-08-16

Gadolinium Zeolite
    Start date: 2001-05-03
    End date: 2001-05-03

Gadolinium Zeolite
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2001-03-05
    End date: 2001-03-05

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2001-04-25
    End date: 2001-04-25

Magnevist
    Indication: Angiogram
    Start date: 2001-05-03
    End date: 2001-05-03

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Multihance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Multihance
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Dosage: dose reported as eight 20ml vials (160ml)
    Start date: 2005-09-20
    End date: 2005-09-20

Omniscan
    Dosage: route reported as ^first via distal port and then via the proximal port^
    Indication: Angiogram
    Start date: 2003-12-04
    End date: 2003-12-04

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-05-23
    End date: 2003-05-23

Omniscan
    Dosage: dose reported as ^11^ 20ml vials
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-09-01
    End date: 2005-09-01

Optimark
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2005-08-16
    End date: 2005-08-16

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Prohance
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Epogen; Imdur; Folic Acid; Potassium Chloride; Lovastatin; Diltiazem; Furosemide; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renagel; Potassium Chloride; Amiodarone HCL; Hydralazine HCL; Aspirin; Niferex; Coreg; Plendil; Venofer; Zemplar



Possible Optimark side effects in 44 year old female

Reported by a physician from United States on 2012-07-18

Patient: 44 year old female, weighing 130.0 kg (286.0 pounds)

Reactions: Pain, Fear, Scleroderma, Hand Deformity, Skin Discolouration, Oedema, Musculoskeletal Stiffness, Injury, Systemic Sclerosis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Sclerodactylia, Anxiety, Emotional Distress, Arthralgia, Gait Disturbance, Mobility Decreased

Drug(s) suspected as cause:
Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Optimark

Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-02-06

Optimark
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-05-31

Optimark
    Dosage: unk
    Start date: 2005-08-31

Other drugs received by patient: Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Coumadin; Accupril; Atenolol; Epogen; Renagel; Calcitriol; Diovan; Norvasc



Possible Optimark side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-12

Patient: 58 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Skin Hypertrophy, Deformity, Skin Plaque, Skin Tightness, Gait Disturbance, Skin Fibrosis, Mobility Decreased, Scar

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Sensipar; Ativan; Lisinopril; Loperamide; Folic Acid; Tylenol W / Codeine NO. 3; Magnesium Oxide; Plavix; Epogen; Calcijex; Zosyn; Ambien; Vitamin K1; Clonidine; Albumin (Human); Roxanol; Velcade; Adenosine; Aspirin; Dexamethasone; Acetaminophen; Compazine; Dilaudid; Foltx; Diflucan; Vancomycin; Potassium Chloride; Bactrim DS; Ciprofloxacin HCL; Hydroxyzine; Acyclovir; Mucomyst; Biaxin; Metoprolol Tartrate; Atarax; Cyclophosphamide; Norco; Neurontin; Digoxin; Ativan; Prevacid; Dexamethasone; Zoloft; Vitamin K1; Ocean; Senokot; Neupogen; Bicitra; Allopurinol; Pravachol; Levaquin; Phoslo; Gentamicin; Nephrocaps; Adriamycin PFS; Simethicone; Zemplar; Plendil; Midodrine Hydrochloride; Renaphro; Renagel; Ativan; Oxacillin; Etoposide; Reglan; Reglan; Compazine; Warfarin Sodium; Prograf



Possible Optimark side effects in 51 year old female

Reported by a lawyer from United States on 2012-07-09

Patient: 51 year old female, weighing 64.1 kg (141.0 pounds)

Reactions: Peripheral Coldness, Pruritus, Skin Exfoliation, Pain, Erythema, Skin Fissures, Joint Stiffness, Skin Discolouration, Dermatitis, Joint Range of Motion Decreased, Oedema Peripheral, Skin Haemorrhage, Fibrosis, Injury, Pain in Extremity, Motor Dysfunction, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Sclerodactylia, Skin Tightness, Emotional Distress, Anxiety, Burning Sensation, Dysstasia, Activities of Daily Living Impaired, Insomnia, Mobility Decreased, Scar

Drug(s) suspected as cause:
Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2001-01-11
    End date: 2001-01-11

Magnevist
    Indication: Arteriovenous Fistula Operation
    Start date: 2006-11-28
    End date: 2006-11-28

Magnevist
    Dosage: unk, once
    Indication: Venous Pressure Increased
    Start date: 2004-12-09
    End date: 2004-12-09

Magnevist
    Indication: Dialysis Efficacy Test
    Start date: 2006-09-26
    End date: 2006-09-26

Magnevist
    Indication: Dialysis Device Insertion

Multihance
    Indication: Fistulogram

Multihance
    Indication: Venogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Fistulogram

Omniscan
    Indication: Venogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Venogram

Optimark
    Indication: Fistulogram

Prohance
    Indication: Venogram

Prohance
    Indication: Fistulogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Levothroid; Atenolol; Phoslo; Epoetin NOS; PEG-3350 and Electrolytes; Levothroid; Calcium Carbonate; Renagel; Epogen; Procardia XL; Pravachol; Sensipar; Vitamin B12; Imodium; Cardizem; Prednisone; Amiodarone HCL; Allopurinol; Immune Globulin NOS; Benadryl; Omeprazole; Protonix; Renagel; Plendil; Immune Globulin NOS; Acetaminophen; Pravastatin; Atenolol; Coumadin; Reglan; Vicodin; Nephro-Vite [vitamins Nos]; Immune Globulin NOS; Immune Globulin NOS; Acetaminophen; Nitroglycerin; Tramadol HCL; Coumadin; Calcium Carbonate; Sensipar; Cyclosporine; Acetaminophen; Benadryl; Benadryl; Calcitriol; Fosrenol; Metoclopramide; Metoprolol Tartrate; Nifedipine; Acetaminophen; Benadryl; Ureacin; Loperamide; Corticosteroids; Coumadin; Protonix; Allopurinol; Prilosec; Immune Globulin NOS; Acetaminophen; Acetaminophen; Benadryl



Possible Optimark side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-06

Patient: female

Reactions: Pain, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Fibrosis, Injury, Disability

Drug(s) suspected as cause:
Magnevist
    Indication: Angiogram

Magnevist
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram



Possible Optimark side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: 54 year old male

Reactions: Pruritus, Muscle Contractions Involuntary, Pain, Abasia, Neuropathic Ulcer, Erythema, Muscle Rigidity, Neuropathy Peripheral, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Muscle Spasms, Excoriation, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Emotional Distress, Arthralgia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-11-29

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2000-12-12
    End date: 2000-12-12

Magnevist

Omniscan

Optimark

Other drugs received by patient: Epoetin Alfa; Phoslo; Lorazepam; Misoprostol; Cefazolin Sodium; Vitamin E; Vitamin D; Amiodarone Hydrochloride; Lansoprazole; Humulin R; Calcium Acetate; Verapamil HCL; Atacand HCT; Minoxidil; Cytotec



Possible Optimark side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-28

Patient: male, weighing 83.0 kg (182.6 pounds)

Reactions: Pruritus, Pain, Quality of Life Decreased, Muscular Weakness, Orthostatic Hypotension, DRY Skin, Stasis Dermatitis, Nephrogenic Systemic Fibrosis, Rash, Skin Hypertrophy, Skin Tightness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Mobility Decreased

Drug(s) suspected as cause:
Magnevist

Magnevist
    Indication: Angiogram

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain

Magnevist
    Dosage: 20 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1998-05-18
    End date: 1998-05-18

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Angiogram

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Angiogram

Optimark
    Indication: Angiogram

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Angiogram

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Pepcid; Meclizine; Prednisone TAB; Diovan; Plavix; Nexium; Flomax; Warfarin Sodium; Covera-HS; Norvasc; Nephrocaps [vit C,vit H,b12,b9,b3,pantothen Ac,b6,b2,b1 Hcl]; Coumadin; Epogen; Monopril; Cytoxan; Accupril; Aspirin; Sensipar; Novolin [insulin]; Hydralazine Hydrochloride; Ancef; Acetaminophen; Kayexalate; Humulin [insulin Human Injection, Isophane]; Norvasc; Phoslo; Catapres; Prevacid; Renvela; Lasix; Amiodarone Hydrochloride; Ascorbic Acid; Fish OIL; Sodium Polystyrene Sulfonate; Procrit; Zaroxolyn; Diuril; Darvocet; Neurontin; Renagel; Clonidine; Levothyroxine; Demadex; Potassium Chloride; Verapamil; Percocet; Lopressor; Lipitor



Possible Optimark side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25

Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Fibrosis, Cellulitis, Pain of Skin, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Rash, Deformity, Skin Plaque, Skin Tightness, Scar, Skin Fibrosis, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Bicitra; Foltx; Plavix; Dexamethasone; Acetaminophen; Adriamycin PFS; Compazine; Dilaudid; Pravachol; Phoslo; Vitamin K1; Etoposide; Reglan; Hydroxyzine; Plendil; Neupogen; Acyclovir; Digoxin; Mucomyst; Renagel; Calcijex; Levaquin; Simethicone; Renaphro; Sensipar; Biaxin; Dexamethasone; Zosyn; Ciprofloxacin; Ocean; Loperamide; Senokot; Clonidine; Albumin (Human); Diflucan; Magnesium Oxide; Potassium Chloride; Gentamicin; Ambien; Compazine; Velcade; Adenosine; Ativan; Lisinopril; Epogen; Oxacillin; Reglan; Zemplar; Roxanol; Allopurinol; Tylenol W / Codeine NO. 3; Ativan; Zoloft; Nephrocaps; Vitamin K1; Cyclophosphamide; Norco; Midodrine Hydrochloride; Warfarin Sodium; Prograf; Folic Acid; Ativan; Aspirin; Prevacid; Metoprolol Tartrate; Vancomycin; Bactrim DS; Atarax; Neurontin



Possible Optimark side effects in 58 year old female

Reported by a consumer/non-health professional from United States on 2012-06-22

Patient: 58 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Scab, Skin Burning Sensation, Skin Hyperpigmentation, Joint Stiffness, Anhedonia, Oedema Peripheral, Skin Swelling, Peau D'orange, Pain in Extremity, Muscular Weakness, Skin Disorder, Skin Induration, Livedo Reticularis, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Rash Macular, Anxiety, Mobility Decreased, Scar, Skin Fibrosis

Drug(s) suspected as cause:
Magnevist
    Dosage: 20 ml, unk
    Indication: Imaging Procedure
    Start date: 2003-12-20

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2005-05-26
    End date: 2005-05-26

Magnevist
    Dosage: 15 ml, unk
    Indication: Angiogram
    Start date: 2006-05-30

Multihance
    Indication: Imaging Procedure

Omniscan
    Indication: Imaging Procedure

Optimark
    Indication: Imaging Procedure

Prohance
    Indication: Imaging Procedure

Other drugs received by patient: Klonopin; Calcitriol; Norvasc; Zemplar; Epogen; Folbee; Immunosuppressive Agents; Sensipar; Plavix; Colchicine; Renagel; Robaxin; Synthroid; Levothyroxine Sodium; Phoslo; Immunosuppressive Agents; Corticosteroids; Hormones and Related Agents; Coumadin; Gabapentin; Antithrombotic Agents; Steroid Antibacterials; Midodrine Hydrochloride; Aspirin; Neurontin; Iron Supplement; Nephrocaps



Possible Optimark side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20

Patient: 59 year old male

Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Post Thrombotic Syndrome, Skin Discolouration, Induration, Oedema Peripheral, Fibrosis

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram Peripheral
    Start date: 2003-10-24
    End date: 2003-10-24

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 2003-07-17
    End date: 2003-07-17

Magnevist

Omniscan

Optimark

Other drugs received by patient: Verapamil; Lasix; Coumadin; Clonidine; Epogen; Minoxidil; Albuterol; Calcitriol; Lanoxin; Renagel; Sensipar; Glyburide; Flovent; Insulin; Iron Sulfatethiamin Compound TAB



Possible Optimark side effects in female

Reported by a physician from United States on 2012-06-18

Patient: female

Reactions: Abdominal Pain, Pulmonary Hypertension, Pruritus, Contusion, Nocturia, Hyperhidrosis, Cardiomegaly, Pericardial Effusion, Off Label Use, Biliary Dilatation, Melanocytic Naevus, Open Wound, Nephrogenic Systemic Fibrosis, Joint Swelling, Impaired Gastric Emptying, Mobility Decreased, Renal Transplant, Wheezing, Chills, Morganella Infection, Polyuria, Constipation, Splenic Infarction, Gastritis, Myalgia, Weight Increased, Fatigue, Hepatomegaly, Skin Ulcer, Dizziness, Pleural Effusion, Musculoskeletal Stiffness, Cholecystitis, Splenomegaly, Decreased Appetite, Device Related Sepsis, Nausea, Muscular Weakness, Rash, Hypercoagulation, Cerebrovascular Accident, Ascites, Arthralgia, Bradycardia, Renal Tubular Necrosis, Proteus Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Optimark
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2006-08-02
    End date: 2006-08-02

Optimark
    Dosage: 20 ml, single
    Indication: Angiogram
    Start date: 2006-08-05
    End date: 2006-08-05

Other drugs received by patient: Metoclopramide; Procardia XL; Epogen; Lisinopril; Renagel; Colace; Micardis; Terazosin HCL; Calcium Acetate; Novolog; Levaquin; Metoprolol Succinate Extended Release; Flagyl



Possible Optimark side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-18

Patient: 59 year old male

Reactions: Muscular Weakness, Hemiparesis, Nephrogenic Systemic Fibrosis, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Post Thrombotic Syndrome, Oedema Peripheral, Induration, Fibrosis

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram Peripheral
    Start date: 2003-10-24
    End date: 2003-10-24

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 2003-07-17
    End date: 2003-07-17

Magnevist

Omniscan

Optimark

Other drugs received by patient: Albuterol; Minoxidil; Renagel; Insulin; Calcitriol; Lanoxin; Verapamil; Lasix; Epogen; Sensipar; Flovent; Coumadin; Glyburide; Clonidine; Iron Sulfatethiamin Compound TAB



Possible Optimark side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: 54 year old male

Reactions: Abasia, Pain, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Emotional Distress, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2000-12-12
    End date: 2000-12-12

Magnevist

Omniscan

Optimark



Possible Optimark side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: 59 year old male

Reactions: Coronary Artery Disease, Atrial Fibrillation, Muscular Weakness, Venous Insufficiency, Nephrogenic Systemic Fibrosis, Hemiparesis, Cardiomyopathy, Cardiogenic Shock, Cerebrovascular Accident, Post Thrombotic Syndrome, Skin Discolouration, Induration, Fibrosis

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram Peripheral
    Start date: 2003-10-24
    End date: 2003-10-24

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Angiogram
    Start date: 2003-07-17
    End date: 2003-07-17

Magnevist

Omniscan

Optimark

Other drugs received by patient: Verapamil; Minoxidil; Insulin; Sensipar; Albuterol; Calcitriol; Epogen; Lanoxin; Renagel; Coumadin; Iron Sulfatethiamin Compound TAB; Glyburide; Clonidine; Flovent; Lasix



Possible Optimark side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-11

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Nephrogenic Systemic Fibrosis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Contrast Media
    Indication: Decubitus Ulcer
    Start date: 2005-04-14
    End date: 2005-04-14

Contrast Media
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Magnevist

Multihance
    Indication: Diagnostic Procedure

Omniscan
    Indication: Liver Disorder
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Neck Pain
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Osteomyelitis
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Optimark

Prohance
    Indication: Renal Mass
    Start date: 2003-07-03
    End date: 2003-07-03

Prohance
    Indication: Renal Scan
    Start date: 2003-07-03
    End date: 2003-07-03

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Other drugs received by patient: Plavix; Iron; Clonidine; Calcitriol; Proamatine; Epogen; Renvela; Cozaar; Calcium Carbonate; Metoprolol Tartrate; Sensipar; Rena-Vite; Phoslo; Hectorol; Renagel; Amlodipine; Fosrenol; Lisinopril; Foltx



Possible Optimark side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: 58 year old female, weighing 77.6 kg (170.6 pounds)

Reactions: Skin Exfoliation, Pain, Skin Hyperpigmentation, Erythema, Joint Stiffness, Fatigue, Joint Range of Motion Decreased, Oedema Peripheral, Oedema, Musculoskeletal Stiffness, Fibrosis, Cellulitis, Pain of Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Skin Hypertrophy, Rash, Deformity, Skin Tightness, Skin Plaque, Scar, Mobility Decreased, Skin Fibrosis

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-05-20
    End date: 2005-05-20

Gadolinium IN Unspecified Drug
    Indication: Angiogram

Gadolinium IN Unspecified Drug
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-31
    End date: 2004-10-31

Magnevist
    Dosage: 20 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2003-09-27
    End date: 2003-09-27

Magnevist
    Dosage: unk
    Indication: Computerised Tomogram Abdomen
    Start date: 2004-10-03
    End date: 2004-10-03

Magnevist
    Dosage: unk
    Start date: 2004-11-10
    End date: 2004-11-10

Magnevist
    Dosage: unk
    Start date: 2004-12-13
    End date: 2004-12-13

Magnevist
    Dosage: unk
    Start date: 2004-07-01
    End date: 2004-07-01

Magnevist
    Dosage: unk
    Indication: Imaging Procedure
    Start date: 2004-10-29
    End date: 2004-10-29

Magnevist
    Dosage: unk
    Indication: Angiogram
    Start date: 2005-02-17
    End date: 2005-02-17

Magnevist
    Dosage: 20 ml, once
    Start date: 2005-05-19
    End date: 2005-05-19

Magnevist
    Dosage: unk, once
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-01-15
    End date: 2004-01-15

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Ativan; Biaxin; Acetaminophen; Ciprofloxacin; Nephrocaps; Cyclophosphamide; Etoposide; Neupogen; Neurontin; Warfarin Sodium; Phoslo; Loperamide; Hydroxyzine; Acyclovir; Zoloft; Vitamin K1; Dilaudid; Albumin (Human); Midodrine Hydrochloride; Foltx; Digoxin; Pravachol; Dexamethasone; Epogen; Gentamicin; Ambien; Clonidine; Bicitra; Mucomyst; Magnesium Oxide; Calcijex; Zosyn; Vitamin K1; Adriamycin PFS; Ocean; Reglan; Compazine; Roxanol; Velcade; Allopurinol; Adenosine; Sensipar; Diflucan; Renagel; Ativan; Ativan; Prevacid; Bactrim DS; Simethicone; Norco; Prograf; Tylenol W / Codeine NO. 3; Dexamethasone; Reglan; Plendil; Renaphro; Folic Acid; Aspirin; Plavix; Lisinopril; Metoprolol Tartrate; Levaquin; Vancomycin; Potassium Chloride; Atarax; Oxacillin; Zemplar; Compazine; Senokot



Possible Optimark side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2005-04-14
    End date: 2005-04-14

Magnevist

Multihance

Omniscan
    Dosage: 15 ml, unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 2004-10-15
    End date: 2004-10-15

Omniscan
    Dosage: 30 ml, once
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2004-07-13
    End date: 2004-07-13

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging Abdominal

Optimark

Prohance
    Dosage: 17 ml, once
    Indication: Nuclear Magnetic Resonance Imaging Abdominal
    Start date: 2003-07-03
    End date: 2003-07-03

Prohance
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2005-04-14
    End date: 2005-04-14

Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx



Possible Optimark side effects in female

Reported by a lawyer from United States on 2012-06-01

Patient: female

Reactions: Nephrogenic Systemic Fibrosis

Drug(s) suspected as cause:
Optimark



Possible Optimark side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01

Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)

Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Skin Hyperpigmentation, Scleroderma, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Rash Papular, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Sclerodactylia, Skin Tightness, Macule, Mobility Decreased

Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-13
    End date: 1999-10-13

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2007-03-21
    End date: 2007-03-21

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-11-18
    End date: 2008-11-18

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 1999-10-28
    End date: 1999-10-28

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-01-14
    End date: 2006-01-14

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging Brain
    Start date: 1999-09-20
    End date: 1999-09-20

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Fistulogram
    Start date: 1999-10-08
    End date: 1999-10-08

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2006-02-04
    End date: 2006-02-04

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-03-19
    End date: 2008-03-19

Gadolinium IN Unspecified Drug
    Dosage: unk
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 1999-09-27
    End date: 1999-09-27

Gadolinium IN Unspecified Drug
    Dosage: unk
    Start date: 2008-08-13
    End date: 2008-08-13

Magnevist
    Indication: Nuclear Magnetic Resonance Imaging

Multihance
    Indication: Nuclear Magnetic Resonance Imaging

Omniscan
    Indication: Nuclear Magnetic Resonance Imaging

Optimark
    Indication: Nuclear Magnetic Resonance Imaging

Prohance
    Indication: Nuclear Magnetic Resonance Imaging

Other drugs received by patient: Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Hydrocodone Bitartrate + Acetaminophen; Phoslo; Calcium Acetate; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Renvela



Possible Optimark side effects in male

Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-06-01

Patient: male

Reactions: Syncope, Convulsion

Drug(s) suspected as cause:
Optimark
    Dosage: 10 ml, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2012-04-03
    End date: 2012-04-03

Optiray 160
    Dosage: 10 ml, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-03
    End date: 2012-04-03



Possible Optimark side effects in male

Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-06-01

Patient: male

Reactions: Syncope, Convulsion

Drug(s) suspected as cause:
Optimark
    Dosage: 10 ml, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2012-04-14
    End date: 2012-04-14

Optiray 160
    Dosage: 10 ml, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-14
    End date: 2012-04-14



Possible Optimark side effects in female

Reported by a physician from United States on 2012-06-01

Patient: female

Reactions: Atelectasis, Lymphadenopathy, Hyperkalaemia, Fall, Gastritis, Dyspnoea Exertional, Fatigue, Basal Cell Carcinoma, Hyperparathyroidism, Colon Adenoma, Graft Thrombosis, Pneumoperitoneum, Bone Giant Cell Tumour Benign, Melanocytic Naevus, Splenomegaly, Localised Infection, Pneumonia, Dyspnoea, Adnexa Uteri Mass, Excoriation, Haemorrhoids, Muscular Weakness, Nephrogenic Systemic Fibrosis, Hypoaesthesia, Osteopenia, Paraesthesia, Skin Plaque, Cholelithiasis, Skin Papilloma, Sleep Disorder, Diarrhoea, Aortic Dilatation, Gait Disturbance, Asthenia, Venous Injury

Drug(s) suspected as cause:
Optimark
    Dosage: unk, single
    Start date: 2002-06-27
    End date: 2002-06-27

Optimark
    Dosage: unk, single
    Start date: 2003-04-17
    End date: 2003-04-17

Optimark
    Dosage: unk, single
    Indication: Nuclear Magnetic Resonance Imaging
    Start date: 2002-05-16
    End date: 2002-05-16

Other drugs received by patient: Zerit; Prevacid; Viracept; Reglan; Epogen; Lamivudine; Dapsone; Klonopin; Phoslo



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012